A 360-degree overview of paediatric NAFLD: Recent insights

Journal of Hepatology

Volumn 58, Issue 6, 2013, Pages 1218-1229

  Nobili, Valerio ^a   Svegliati Baroni, Gianluca ^b   Alisi, Anna ^a   Miele, Luca ^c   Valenti, Luca ^d   Vajro, Pietro ^e  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF SALERNO   (Italy)

Author keywords

Children; Fibrosis; NAFLD; NASH

Indexed keywords

ADIPOCYTOKINE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DOCOSAHEXAENOIC ACID; FARNESOID X RECEPTOR; FATTY ACID; INCRETIN; INSULIN; LEPTIN; LIPID; MERCAPTAMINE; PENTOXIFYLLINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; POLYUNSATURATED FATTY ACID; PROBIOTIC AGENT; TRIACYLGLYCEROL; URSODEOXYCHOLIC ACID; CELL RECEPTOR;

ADIPOSE TISSUE; BARIATRIC SURGERY; BODY MASS; CARDIOMETABOLIC RISK; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE RELEASE; DIETARY INTAKE; DISEASE COURSE; ECHOGRAPHY; ENZYME ACTIVITY; EPIDEMIC; FATTY LIVER; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; INSULIN SENSITIVITY; KUPFFER CELL; LIFESTYLE MODIFICATION; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIPOTOXICITY; LIVER FIBROSIS; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEDENTARY LIFESTYLE; SINGLE NUCLEOTIDE POLYMORPHISM; STEM CELL; TRIACYLGLYCEROL BLOOD LEVEL; CHILD; GENETICS; LIVER CIRRHOSIS; PHYSIOLOGY;

CHILD; FATTY LIVER; HUMANS; LIVER CIRRHOSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RISK FACTORS;

EID: 84877920825     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.12.003     Document Type: Review

References (161)

1. E.M. Brunt Pathology of nonalcoholic fatty liver disease Nat Rev Gastroenterol Hepatol 7 2010 195 203
2. C.P. Day Non-alcoholic fatty liver disease: a massive problem Clin Med 11 2011 176 178
3. G. Musso, R. Gambino, M. Cassader, and G. Pagano Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity Ann Med 43 2011 617 649
4. A. Alisi, M. Manco, A. Vania, and V. Nobili Pediatric nonalcoholic fatty liver disease in 2009 J Pediatr 155 2009 469 474
5. A.E. Feldstein, P. Charatcharoenwitthaya, S. Treeprasertsuk, J.T. Benson, F.B. Enders, and P. Angulo The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years Gut 58 2009 1538 1544
6. L. Pacifico, V. Nobili, C. Anania, P. Verdecchia, and C. Chiesa Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk World J Gastroenterol 17 2011 3082 3091
7. J.B. Schwimmer, P.E. Pardee, J.E. Lavine, A.K. Blumkin, and S. Cook Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease Circulation 118 2008 277 283
8. R. Kelishadi, S.R. Cook, A. Adibi, Z. Faghihimani, S. Ghatrehsamani, and A. Beihaghi Association of the components of the metabolic syndrome with non-alcoholic fatty liver disease among normal-weight, overweight and obese children and adolescents Diabetol Metab Syndr 1 2009 29
9. A. Alisi, M. Locatelli, and V. Nobili Nonalcoholic fatty liver disease in children Curr Opin Clin Nutr Metab Care 13 2010 397 402
10. A. Alisi, A.E. Feldstein, A. Villani, M. Raponi, and V. Nobili Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach Nat Rev Gastroenterol Hepatol 9 2012 152 161
11. D.R. Mager, C. Patterson, S. So, C.D. Rogenstein, L.J. Wykes, and E.A. Roberts Dietary and physical activity patterns in children with fatty liver Eur J Clin Nutr 64 2010 628 635
12. A. Alisi, S. Cianfarani, M. Manco, C. Agostoni, and V. Nobili Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment Ann Med 44 2012 29 40
13. A.A. Mencin, and J.E. Lavine Advances in pediatric nonalcoholic fatty liver disease Pediatr Clin North Am 58 2011 1375 1392
14. P. Vajro, S. Lenta, P. Socha, A. Dhawan, P. McKiernan, and U. Baumann Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee J Pediatr Gastroenterol Nutr 54 2012 700 713
15. L.A. Adams, and A.E. Feldstein Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis J Dig Dis 12 2011 10 16
16. V. Nobili, A. Alisi, and M. Raponi Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention World J Gastroenterol 15 2009 6017 6022
17. A. Alisi, and V. Nobili Nonalcoholic fatty liver disease: targeted therapy in children-what is the right way? Nat Rev Gastroenterol Hepatol 8 2011 425 426
18. R. Loomba, C.B. Sirlin, J.B. Schwimmer, and J.E. Lavine Advances in pediatric nonalcoholic fatty liver disease Hepatology 50 2009 1282 1293
19. M. Manco, A. Alisi, and V. Nobili Risk of severe liver disease in NAFLD with normal ALT levels: a pediatric report Hepatology 48 2008 2087 2088
20. A. Franzese, P. Vajro, A. Argenziano, A. Puzziello, M.P. Iannucci, and M.C. Saviano Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population Dig Dis Sci 42 1997 1428 1432
21. A.K. Daly, S. Ballestri, L. Carulli, P. Loria, and C.P. Day Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease Expert Rev Gastroenterol Hepatol 5 2011 253 263
22. J.B. Schwimmer, M.A. Celedon, J.E. Lavine, R. Salem, N. Campbell, and N.J. Schork Heritability of non alcoholic fatty liver disease Gastroenterology 136 2009 1585 1592
23. Y.C. Lin, P.F. Chang, S.J. Yeh, K. Liu, and H.C. Chen Risk factors for liver steatosis in obese children and adolescents Pediatr Neonatol 51 2010 149 154
24. I.R. Willner, B. Waters, S.R. Patil, A. Reuben, J. Morelli, and C.A. Riely Ninety patients with non alcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease Am J Gastroenterol 96 2001 2957 2961
25. J.B. Schwimmer, R. Deutsch, T. Kahen, J.E. Lavine, C. Stanley, and C. Behling Prevalence of fatty liver in children and adolescents Pediatrics 118 2006 1388 1393
26. L. Pacifico, E. Poggiogalle, V. Cantisani, G. Menichini, P. Ricci, and F. Ferraro Pediatric nonalcoholic fatty liver disease: a clinical and laboratory challenge World J Hepatol 2 2010 275 288
27. L. Valenti, A. Alisi, E. Galmozzi, A. Bartuli, B. Del Menico, and A. Alterio I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease Hepatology 52 2010 1274 1280
28. S. Romeo, J. Kozlitina, C. Xing, A. Pertsemlidis, D. Cox, and L.A. Pennacchio Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 2008 1461 1465
29. X. Yuan, D. Waterworth, J.R. Perry, N. Lim, K. Song, and J.C. Chambers Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes Am J Hum Genet 83 2008 520 528
30. L. Valenti, A. Al-Serri, A.K. Daly, E. Galmozzi, R. Rametta, and P. Dongiovanni Homozygosity for the PNPLA3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease Hepatology 51 2010 1209 1217
31. S. Sookoian, and C.J. Pirola Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease Hepatology 53 2011 1883 1894
32. L. Valenti, A. Alisi, and V. Nobili I148M PNPLA3 variant and progressive liver disease: a new paradigm in hepatology Hepatology 56 2012 1883 1889
33. E.K. Speliotes, J.L. Butler, C.D. Palmer, B.F. Voight, and J.N. Hirschhorn PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease Hepatology 52 2010 904 912
34. Y. Huang, S. He, J.Z. Li, Y.K. Seo, T.F. Osborne, and J.C. Cohen A feed-forward loop amplifies nutritional regulation of PNPLA3 Proc Natl Acad Sci U S A 107 2010 7892 7897
35. S. He, C. McPhaul, J.Z. Li, R. Garuti, L.N. Kinch, and N.V. Grishin A sequence variation (I148M) in PNPlA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis J Biol Chem 285 2009 6706 6715
36. S. Romeo, F. Sentinelli, V.M. Cambuli, M. Incani, T. Congiu, and V. Matta The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life J Hepatol 53 2010 335 338
37. Y.C. Lin, P.F. Chang, F.C. Hu, W.S. Yang, M.H. Chang, and Y.H. Ni A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children J Pediatr 158 2011 740 744
38. N. Santoro, R. Kursawe, E. D'Adamo, D.J. Dykas, C.K. Zhang, and A.E. Bale A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents Hepatology 52 2010 1281 1290
39. M.I. Goran, R. Walker, K.A. Le, S. Mahurkar, S. Vikman, and J.N. Davis Effects of PNPLA3 on liver fat and metabolic profile in Hispanic children and adolescents Diabetes 59 2010 3127 3130
40. E. Miraglia Del Giudice, A. Grandone, G. Cirillo, N. Santoro, A. Amato, and C. Brienza The association of PNPLA3 variants with liver enzymes in childhood obesity is driven by the interaction with abdominal fat PLoS One 6 2011 e27933
41. J.N. Davis, K.A. Le, R.W. Walker, S. Vikman, D. Spruijt-Metz, and M.J. Weigensberg Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption Am J Clin Nutr 92 2011 1522 1527
42. N. Santoro, M. Savoye, G. Kim, K. Marotto, M.M. Shaw, and B. Pierpont Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6/omega3 PUFA intake PLoS One 7 2012 e37827
43. E.K. Speliotes, L.M. Yerges-Armstrong, J. Wu, R. Hernaez, L.J. Kim, and C.D. Palmer Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits PLoS Genet 7 2011 e1001324
44. N. Santoro, C.K. Zhang, H. Zhao, A.J. Pakstis, G. Kim, and R. Kursawe Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents Hepatology 55 2012 781 789
45. P. Dongiovanni, L. Valenti, R. Rametta, A.K. Daly, V. Nobili, and E. Mozzi Genetic variants regulating insulin receptor signaling are associated with the severity of liver damage in patients with nonalcoholic fatty liver disease Gut 59 2010 267 273
46. A. Al-Serri, Q.M. Anstee, L. Valenti, V. Nobili, J.B. Leathart, and P. Dongiovanni The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies J Hepatol 56 2012 448 454
47. L. Miele, G. Beale, G. Patman, V. Nobili, J. Leathart, and A. Grieco The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease Gastroenterology 135 2008 282 291
48. L. Valenti, V. Nobili, A. Al-Serri, R. Rametta, J.B. Leathart, and M.A. Zappa The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver J Hepatol 55 2011 1409 1414
49. M. Manco, A. Alisi, J.M. Real, F. Equitani, R. Devito, and L. Valenti Early interplay of intra-hepatic iron and insulin resistance in children with non-alcoholic fatty liver disease J Hepatol 55 2011 647 653
50. A. Alisi, L. Da Sacco, G. Bruscalupi, F. Piemonte, N. Panera, and R. De Vito Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease Lab Invest 91 2010 283 293
51. L. Valenti, B.M. Motta, A. Alisi, R. Sartorelli, G. Bonaiuto, and P. Dongiovanni LPIN1 rs13412852 polymorphism in pediatric non-alcoholic fatty liver disease J Pediatr Gastroenterol Nutr 54 2012 588 593
52. C.Z. Larter, S. Chitturi, D. Heydet, and G.C. Farrell A fresh look at NASH pathogenesis. Part 1: the metabolic movers J Gastroenterol Hepatol 25 2010 672 690
53. S.S. Sundaram, P. Zeitler, and K. Nadeau The metabolic syndrome and nonalcoholic fatty liver disease in children Curr Opin Pediatr 21 2009 529 535
54. M. Manco, M. Marcellini, R. Devito, D. Comparcola, M.R. Sartorelli, and V. Nobili Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis Int J Obes (Lond) 32 2008 381 387
55. H.M. Patton, K. Yates, A. Unalp-Arida, C.A. Behling, T.T. Huang, and P. Rosenthal Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease Am J Gastroenterol 105 2010 2093 2102
56. J.S. Lim, M. Mietus-Snyder, A. Valente, J.M. Schwarz, and R.H. Lustig The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome Nat Rev Gastroenterol Hepatol 7 2010 251 264
57. E.W. Kraegen, and G.J. Cooney Free fatty acids and skeletal muscle insulin resistance Curr Opin Lipidol 19 2008 235 241
58. H. Tilg, and A.R. Moschen Insulin resistance, inflammation, and non-alcoholic fatty liver disease Trends Endocrinol Metab 19 2008 371 379
59. M. Malaguarnera, M. Di Rosa, F. Nicoletti, and L. Malaguarnera Molecular mechanisms involved in NAFLD progression J Mol Med 87 2009 679 695
60. G. Baffy Kupffer cells in non-alcoholic fatty liver disease: the emerging view J Hepatol 51 2009 212 223
61. A. Alisi, R. Carsetti, and V. Nobili Pathogen- or damage-associated molecular patterns during nonalcoholic fatty liver disease development Hepatology 54 2011 1500 1502
62. A. Alisi, M. Manco, R. Devito, F. Piemonte, and V. Nobili Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children J Pediatr Gastroenterol Nutr 50 2010 645 649
63. P. Angulo Nonalcoholic fatty liver disease N Engl J Med 346 2002 1221 1231
64. E.M. Brunt, D.E. Kleiner, L.A. Wilson, P. Belt, and B.A. Neuschwander-Tetri Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings Hepatology 53 2011 810 820
65. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, and O.W. Cummings Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
66. S.H. Caldwell, and D.M. Crespo The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease J Hepatol 40 2004 578 584
67. E.E. Powell, W.G. Cooksley, R. Hanson, J. Searle, J.W. Halliday, and L.W. Powell The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 11 1990 74 80
68. F. Marra, A. Gastaldelli, G. Svegliati Baroni, G. Tell, and C. Tiribelli Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis Trends Mol Med 14 2008 72 81
69. E. Vanni, E. Bugianesi, A. Kotronen, S. De Minicis, H. Yki-Jarvinen, and G. Svegliati-Baroni From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis 42 2010 320 330
70. S. De Minicis, and G. Svegliati-Baroni Fibrogenesis in nonalcoholic steatohepatitis Expert Rev Gastroenterol Hepatol 5 2011 179 187
71. T. Kisseleva, and D.A. Brenner Is it the end of the line for the EMT? Hepatology 53 2011 1433 1435
72. V. Nobili, G. Carpino, A. Alisi, A. Franchitto, G. Alpini, and R. De Vito Hepatic progenitor cells activation, fibrosis and adipokines production in pediatric nonalcoholic fatty liver disease Hepatology 56 2012 2142 2153
73. T. Adachi, H. Togashi, A. Suzuki, S. Kasai, J. Ito, and K. Sugahara NAD(P)H oxidase plays a crucial role in PDGF-induced proliferation of hepatic stellate cells Hepatology 41 2005 1272 1281
74. R. Bataller, R.F. Schwabe, Y.H. Choi, L. Yang, Y.H. Paik, and J. Lindquist NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis J Clin Invest 112 2003 1383 1394
75. S. De Minicis, E. Seki, C. Oesterreicher, B. Schnabl, R.F. Schwabe, and D.A. Brenner Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells Hepatology 48 2008 2016 2026
76. J.M. Friedman, and J.L. Halaas Leptin and the regulation of body weight in mammals Nature 395 1998 763 770
77. I.A. Leclercq, G.C. Farrell, R. Schriemer, and G.R. Robertson Leptin is essential for the hepatic fibrogenic response to chronic liver injury J Hepatol 37 2002 206 213
78. M. Adachi, and D.A. Brenner High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase Hepatology 47 2008 677 685
79. F. Marra, and C. Bertolani Adipokines in liver diseases Hepatology 50 2009 957 969
80. H. Tilg The role of cytokines in non-alcoholic fatty liver disease Dig Dis 28 2010 179 185
81. G. Baskol, M. Baskol, and D. Kocer Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis Clin Biochem 40 2007 776 780
82. N. Chalasani, M.A. Deeg, and D.W. Crabb Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis Am J Gastroenterol 99 2004 1497 1502
83. I.A. Leclercq, G.C. Farrell, J. Field, D.R. Bell, F.J. Gonzalez, and G.R. Robertson CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis J Clin Invest 105 2000 1067 1075
84. S. De Minicis, R. Bataller, and D.A. Brenner NADPH oxidase in the liver: defensive, offensive, or fibrogenic? Gastroenterology 131 2006 272 275
85. S. De Minicis, E. Seki, Y.H. Paik, C.H. Osterreicher, Y. Kodama, and J. Kluwe Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis Hepatology 52 2010 1420 1430
86. A. Mizrahi, S. Molshanski-Mor, C. Weinbaum, Y. Zheng, M. Hirshberg, and E. Pick Activation of the phagocyte NADPH oxidase by rac guanine nucleotide exchange factors in conjunction with ATP and nucleoside diphosphate kinase J Biol Chem 280 2005 3802 3811
87. M.D. Wheeler, H. Kono, M. Yin, M. Nakagami, T. Uesugi, and G.E. Arteel The role of Kupffer cell oxidant production in early ethanol-induced liver disease Free Radic Biol Med 31 2001 1544 1549
88. R. Bataller, P. Sancho-Bru, P. Gines, and D.A. Brenner Liver fibrogenesis: a new role for the renin-angiotensin system Antioxid Redox Signal 7 2005 1346 1355
89. A. Berson, V. De Beco, P. Letteron, M.A. Robin, C. Moreau, and J. El Kahwaji Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes Gastroenterology 114 1998 764 774
90. A. Sanyal Nonalcoholic steatohepatitis Indian J Gastroenterol 20 2001 C64 C70
91. M.D. Weltman, G.C. Farrell, P. Hall, M. Ingelman-Sundberg, and C. Liddle Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis Hepatology 27 1998 128 133
92. S. Seki, T. Kitada, T. Yamada, H. Sakaguchi, K. Nakatani, and K. Wakasa In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases J Hepatol 37 2002 56 62
93. A.E. Feldstein, N.W. Werneburg, A. Canbay, M.E. Guicciardi, S.F. Bronk, and R. Rydzewski Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway Hepatology 40 2004 185 194
94. G. Svegliati Baroni, L. D'Ambrosio, G. Ferretti, A. Casini, A. Di Sario, and R. Salzano Fibrogenic effect of oxidative stress on rat hepatic stellate cells Hepatology 27 1998 720 726
95. S.J. Karpen Nuclear receptor regulation of hepatic function J Hepatol 36 2002 832 850
96. A.I. Shulman, and D.J. Mangelsdorf Retinoid x receptor heterodimers in the metabolic syndrome N Engl J Med 353 2005 604 615
97. E.R. Kallwitz, A. McLachlan, and S.J. Cotler Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease World J Gastroenterol 14 2008 22 28
98. J. Browning, and J. Horton Molecular mediators of hepatic steatosis and liver injury J Clin Invest 114 2004 147 152
99. M. Trauner, and E. Halilbasic Nuclear receptors as new perspective for the management of liver diseases Gastroenterology 140 2011 1120-5 e1-12
100. S. Barlow, and The Expert Committee Expert committee recommendations on the assessment, prevention, and treatment of child and adolescent overweight and obesity, summary report Pediatrics 120 2007 S164 S192
101. G.P. August, S. Caprio, I. Fennoy, M. Freemark, F.R. Kaufman, and R.H. Lustig Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion J Clin Endocrinol Metab 93 2008 4576 4599
102. J.B. Schwimmer, N. McGreal, R. Deutsch, M.J. Finegold, and J.E. Lavine Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents Pediatrics 115 2005 e561 e565
103. G. Bedogni, A. Gastaldelli, M. Manco, A. De Col, F. Agosti, and C. Tiribelli Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children Nutr Metab Cardiovasc Dis 22 2012 120 126
104. D.A. Patel, S.R. Srinivasan, W. Chen, and G.S. Berenson Serum alanine aminotransferase and its association with metabolic syndrome in children: the bogalusa heart study Metab Syndr Relat Disord 9 2011 211 216
105. V. Calcaterra, T. Muratori, C. Klersy, R. Albertini, C. Caramagna, and V. Brizzi Early-onset metabolic syndrome in prepubertal obese children and the possible role of alanine aminotransferase as marker of metabolic syndrome Ann Nutr Metab 58 2011 307 314
106. V. Nobili, A. Reale, A. Alisi, G. Morino, I. Trenta, and M. Pisani Elevated serum ALT in children presenting to the emergency unit: relationship with NAFLD Dig Liver Dis 41 2009 749 752
107. S. Kechagias, A. Ernersson, O. Dahlqvist, P. Lundberg, T. Lindström, and F.H. Nystrom Fast Food Study Group. Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects Gut 57 2008 649 654
108. G. Rodríguez, S. Gallego, C. Breidenassel, L.A. Moreno, and F. Gottrand Is liver transaminases assessment an appropriate tool for the screening of non-alcoholic fatty liver disease in at risk obese children and adolescents? Nutr Hosp 25 2010 712 717
109. S. Kechagias, A. Ernersson, O. Dahlqvist, P. Lundberg, T. Lindström, and F.H. Nystrom Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects Gut 57 2008 649 654
110. P. Mofrad, M.J. Contos, M. Haque, C. Sargeant, R.A. Fisher, and V.A. Luketic Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values Hepatology 37 2003 1286 1292
111. J.B. Schwimmer, W. Dunn, G.J. Norman, P.E. Pardee, M.S. Middleton, and N. Kerkar SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease Gastroenterology 138 2010 1357 1364
112. S. Saadeh, Z.M. Younossi, E.M. Remer, T. Gramlich, J.P. Ong, and M. Hurley The utility of radiological imaging in nonalcoholic fatty liver disease Gastroenterology 123 2002 745 750
113. A. Shannon, N. Alkhouri, C. Carter-Kent, L. Monti, R. Devito, and R. Lopez Ultrasonographic quantitative estimation of hepatic steatosis in children with NAFLD J Pediatr Gastroenterol Nutr 53 2011 190 195
114. L. Pacifico, M. Celestre, C. Anania, P. Paolantonio, C. Chiesa, and A. Laghi MRI and ultrasound for hepatic fat quantification: relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease Acta Paediatr 96 2007 542 547
115. N.F. Schwenzer, F. Springer, C. Schraml, N. Stefan, J. Machann, and F. Schick Noninvasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance J Hepatol 51 2009 433 445
116. A. Alisi, R. de Vito, L. Monti, and V. Nobili Liver fibrosis in paediatric liver diseases Best Pract Res Clin Gastroenterol 25 2011 259 268
117. M. Manco, G. Bedogni, M. Marcellini, R. Devito, P. Ciampalini, and M.R. Sartorelli Waist circumference correlates with liver fibrosis in children with non alcoholic steatohepatitis Gut 57 2008 1283 1287
118. V. Nobili, A. Alisi, A. Vania, C. Tiribelli, A. Pietrobattista, and G. Bedogni The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease BMC Med 7 2009 21
119. L. Miele, A. Forgione, G. Gasbarrini, and A. Grieco Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) Transl Res 149 2007 114 125
120. V. Nobili, A. Alisi, G. Torre, R. De Vito, A. Pietrobattista, and G. Morino Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease Transl Res 156 2010 229 234
121. A.E. Feldstein, A. Wieckowska, A.R. Lopez, Y.C. Liu, N.N. Zein, and A.J. McCullough Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicentre validation study Hepatology 50 2009 1072 1078
122. V. Nobili, J. Parkes, G. Bottazzo, M. Marcellini, R. Cross, and D. Newman Performance of ELF serum markers in predicting fibrosis stage in pediatric nonalcoholic fatty liver disease Gastroenterology 136 2009 160 167
123. N. Alkhouri, C. Carter-Kent, R. Lopez, W.M. Rosenberg, M. Pinzani, and G. Bedogni A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis Clin Gastroenterol Hepatol 9 2011 150 155
124. V. Nobili, L. Monti, A. Alisi, C. Lo Zupone, A. Pietrobattista, and P. Tomà Transient elastography for assessment of fibrosis in paediatric liver disease Pediatr Radiol 41 2011 1232 1238
125. L.E. McCurdy, K.E. Winterbottom, S.S. Mehta, and J.R. Roberts Using nature and outdoor activity to improve children's health Curr Probl Pediatr Adolesc Health Care 40 2010 102 117
126. V. Nobili, M. Marcellini, R. Devito, P. Ciampalini, F. Piemonte, and D. Comparcola NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice Hepatology 44 2006 458 465
127. T. Reinehr, C. Schmidt, A.M. Toschke, and W. Andler Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study Arch Dis Child 94 2009 437 442
128. B.G. Koot, O.H. van der Baan-Slootweg, C.L. Tamminga-Smeulders, T.H. Rijcken, J.C. Korevaar, and W.M. van Aalderen Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement Arch Dis Child 96 2011 669 674
129. V. Nobili, M. Manco, R. Devito, V. Di Ciommo, D. Comparcola, and M.R. Sartorelli Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial Hepatology 48 2008 119 128
130. M.F. Abdelmalek, A. Suzuki, C. Guy, A. Unalp-Arida, R. Colvin, and R.J. Johnson Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease Hepatology 51 2010 1961 1971
131. V. Nobili, G. Bedogni, A. Alisi, A. Pietrobattista, A. Alterio, and C. Tiribelli Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomized controlled clinical trial Arch Dis Child 96 2011 350 353
132. S. Zelber-Sagi, V. Ratziu, and R. Oren Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence World J Gastroenterol 17 2011 3377 3389
133. T. Reinehr Effectiveness of lifestyle intervention in overweight children Proc Nutr Soc 70 2011 494 505
134. R.A. Weiner Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease Dig Dis 28 2010 274 279
135. P.E. Pardee, J.E. Lavine, and J.B. Schwimmer Diagnosis and treatment of pediatric non-alcoholic steatohepatitis and the implications for bariatric surgery Semin Pediatr Surg 18 2009 144 151
136. M.A. Fullmer, S.H. Abrams, K. Hrovat, L. Mooney, A.O. Scheimann, and J.B. Hillman Nutritional strategy for adolescents undergoing bariatric surgery: report of a working group of the Nutrition Committee of NASPGHAN/NACHRI J Pediatr Gastroenterol Nutr 54 2012 125 135
137. J.E. Lavine, and E. Vitamin Treatment of nonalcoholic steatohepatitis in children: a pilot study J Pediatr 136 2000 734 738
138. P. Vajro, C. Mandato, A. Franzese, E. Ciccimarra, S. Lucariello, and M. Savoia Vitamin E treatment in pediatric obesity-related liver disease: a randomized study J Pediatr Gastroenterol Nutr 38 2004 48 55
139. C.L. Wang, L. Liang, J.F. Fu, C.C. Zou, F. Hong, and J.Z. Xue Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children World J Gastroenterol 14 2008 1598 1602
140. J.E. Lavine, J.B. Schwimmer, and M.L. Van Natta Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial JAMA 305 2011 1659 1668
141. T.A. Nguyen, and A.J. Sanyal Pathophysiology guided treatment of nonalcoholic steatohepatitis J Gastroenterol Hepatol 27 2012 58 64
142. J.B. Schwimmer, M.S. Middleton, R. Deutsch, and J.E. Lavine A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis Aliment Pharmacol Ther 21 2005 871 879
143. V. Nobili, M. Manco, P. Ciampalini, A. Alisi, R. Devito, and E. Bugianesi Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study Clin Ther 30 2008 1168 1176
144. K.J. Nadeau, L.B. Ehlers, P.S. Zeitler, and K. Love-Osborne Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents Pediatr Diabetes 10 2009 5 13
145. A.M. Diehl Hepatic complications of obesity Gastroenterol Clin North Am 39 2010 57 68
146. M.J. Perez, and O. Briz Bile-acid-induced cell injury and protection World J Gastroenterol 15 2009 1677 1689
147. P. Vajro, A. Franzese, G. Valerio, M.P. Iannucci, and N. Aragione Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children J Pediatr 136 2000 739 743
148. P.D. Cani, R. Bibiloni, C. Knauf, A. Waget, A.M. Neyrinck, and N.M. Delzenne Changes in gut microbiota control metabolic endotoxemia-induced inflammation in highfat diet-induced obesity and diabetes in mice Diabetes 57 2008 1470 1481
149. E. Esposito, A. Iacono, G. Bianco, G. Autore, S. Cuzzocrea, and P. Vajro Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats J Nutr 139 2009 905 911
150. A. Iacono, G.M. Raso, R.B. Canani, A. Calignano, and R. Meli Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms J Nutr Biochem 22 2011 699 711
151. C. Loguercio, A. Federico, C. Tuccillo, F. Terracciano, M.V. D'Auria, and C. De Simone Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases J Clin Gastroenterol 39 2005 540 543
152. P. Vajro, C. Mandato, M.R. Licenziati, A. Franzese, D.F. Vitale, and S. Lenta Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease J Pediatr Gastroenterol Nutr 52 2011 740 743
153. G.S. Masterton, J.N. Plevris, and P.C. Hayes Review article: omega-3 fatty acids-a promising novel therapy for non-alcoholic fatty liver disease Aliment Pharmacol Ther 31 2010 679 692
154. J. Shirakawa, H. Fujii, K. Ohnuma, K. Sato, Y. Ito, and M. Kaji Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice Diabetes 60 2011 1246 1257
155. M. Fuchs Non-alcoholic fatty liver disease: the bile acid-activated farnesoid x receptor as an emerging treatment target J Lipids 2012 2012 934396
156. S. Stefano Fiorucci, A. Mencarelli, E. Distrutti, and A. Zampella Farnesoid X receptor: from medicinal chemistry to clinical applications Future Med Chem 4 2012 877 891
157. R. Dohil, S. Schmeltzer, B.L. Cabrera, T. Wang, J. Durelle, and K.B. Duke Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease Aliment Pharmacol Ther 33 2011 1036 1044
158. R. Dohil, L. Meyer, S. Schmeltzer, B.L. Cabrera, J.E. Lavine, and S.A. Phillips The effect of cysteamine bitartrate on adiponectin multimerization in non-alcoholic fatty liver disease and healthy subjects J Pediatr 161 2012 639 645
159. W. Li, L. Zheng, C. Sheng, X. Cheng, L. Qing, and S. Qu Systematic review on the treatment of pentoxifylline in patients with non-alcoholic fatty liver disease Lipids Health Dis 10 2011 49
160. C.O. Zein, L.M. Yerian, P. Gogate, R. Lopez, J.P. Kirwan, and A.E. Feldstein Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial Hepatology 54 2011 1610 1619
161. K. Miura, E. Seki, H. Ohnishi, and D.A. Brenner Role of toll-like receptors and their downstream molecole in the development of nonalcoholic fatty liver disease Gastroenterol Res Pract 2010 2010 362847